Imc Chicago, LLC Amarin Corp Plcuk Transaction History

Imc Chicago, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$3.24 - $5.18 $197,510 - $315,772	-60,960 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$3.94 - $5.84 $6,055 - $8,976	1,537 Added 2.59%	60,960 $311,000
Q2 2021 Aug 06, 2021	SELL	$4.26 - $6.5 $60,602 - $92,469	-14,226 Reduced 19.32%	59,423 $260,000
Q1 2021 May 14, 2021	SELL	$5.03 - $8.8 $290,467 - $508,173	-57,747 Reduced 43.95%	73,649 $457,000
Q4 2020 Feb 17, 2021	SELL	$4.04 - $5.31 $151,847 - $199,581	-37,586 Reduced 22.24%	131,396 $643,000
Q3 2020 Nov 17, 2020	BUY	$3.64 - $7.76 $404,174 - $861,647	111,037 Added 191.62%	168,982 $711,000
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $458,129 - $791,663	-95,843 Reduced 62.32%	57,945 $401,000
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $466,632 - $2.51 Million	116,658 Added 314.19%	153,788 $615,000
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $517,592 - $895,575	37,130 New	37,130 $796,000
Q3 2019 Nov 12, 2019	SELL	$13.89 - $23.16 $341,582 - $569,550	-24,592 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$16.27 - $20.51 $400,111 - $504,381	24,592 New	24,592 $477,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

Stay updated on Imc Chicago, LLC with notifications on news.